REPORT ID 3376

United States Animal Plasma and Derivatives Market Report 2017

Publish Date
13-Dec-17
Pages
103
Format
Electronic (PDF)

In this report, the United States Animal Plasma and Derivatives market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Animal Plasma and Derivatives in these regions, from 2012 to 2022 (forecast).

United States Animal Plasma and Derivatives market competition by top manufacturers/players, with Animal Plasma and Derivatives sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Proliant Inc.
    Thermo Fisher Scientific, Inc.
    Merck KGaA
    Kraeber & Co GmbH
    LAMPIRE Biological Laboratories, Inc.
    Lake Immunogenics, Inc.
    Rocky Mountain Biologicals Inc.
    ANZCO Foods Ltd.
    Auckland BioSciences Ltd.
    Bovogen Biologicals Pty Ltd.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    By Derivatives Type
        Immunoglobulin
        Fibrinogen
        Serum Albumin
        Fetal Bovine Serum
        Thrombin
        New Born Calf Serum
    By Animal Type
        Bovine
        Ovine
        Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Food & Beverages
    Pharmaceuticals
    Cosmetics
    Feed
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Animal Plasma and Derivatives Market Report 2017
1 Animal Plasma and Derivatives Overview
    1.1 Product Overview and Scope of Animal Plasma and Derivatives
    1.2 Classification of Animal Plasma and Derivatives by Product Category
        1.2.1 United States Animal Plasma and Derivatives Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Animal Plasma and Derivatives Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Immunoglobulin
        1.2.4 Fibrinogen
        1.2.5 Serum Albumin
        1.2.6 Fetal Bovine Serum
        1.2.7 Thrombin
        1.2.8 New Born Calf Serum
    1.3 United States Animal Plasma and Derivatives Market by Application/End Users
        1.3.1 United States Animal Plasma and Derivatives Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Food & Beverages
        1.3.3 Pharmaceuticals
        1.3.4 Cosmetics
        1.3.5 Feed
        1.3.6 Others
    1.4 United States Animal Plasma and Derivatives Market by Region
        1.4.1 United States Animal Plasma and Derivatives Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Animal Plasma and Derivatives Status and Prospect (2012-2022)
        1.4.3 Southwest Animal Plasma and Derivatives Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Animal Plasma and Derivatives Status and Prospect (2012-2022)
        1.4.5 New England Animal Plasma and Derivatives Status and Prospect (2012-2022)
        1.4.6 The South Animal Plasma and Derivatives Status and Prospect (2012-2022)
        1.4.7 The Midwest Animal Plasma and Derivatives Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Animal Plasma and Derivatives (2012-2022)
        1.5.1 United States Animal Plasma and Derivatives Sales and Growth Rate (2012-2022)
        1.5.2 United States Animal Plasma and Derivatives Revenue and Growth Rate (2012-2022)

2 United States Animal Plasma and Derivatives Market Competition by Players/Suppliers
    2.1 United States Animal Plasma and Derivatives Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Animal Plasma and Derivatives Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Animal Plasma and Derivatives Average Price by Players/Suppliers (2012-2017)
    2.4 United States Animal Plasma and Derivatives Market Competitive Situation and Trends
        2.4.1 United States Animal Plasma and Derivatives Market Concentration Rate
        2.4.2 United States Animal Plasma and Derivatives Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Animal Plasma and Derivatives Manufacturing Base Distribution, Sales Area, Product Type

3 United States Animal Plasma and Derivatives Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Animal Plasma and Derivatives Sales and Market Share by Region (2012-2017)
    3.2 United States Animal Plasma and Derivatives Revenue and Market Share by Region (2012-2017)
    3.3 United States Animal Plasma and Derivatives Price by Region (2012-2017)

4 United States Animal Plasma and Derivatives Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Animal Plasma and Derivatives Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Animal Plasma and Derivatives Revenue and Market Share by Type (2012-2017)
    4.3 United States Animal Plasma and Derivatives Price by Type (2012-2017)
    4.4 United States Animal Plasma and Derivatives Sales Growth Rate by Type (2012-2017)

5 United States Animal Plasma and Derivatives Sales (Volume) by Application (2012-2017)
    5.1 United States Animal Plasma and Derivatives Sales and Market Share by Application (2012-2017)
    5.2 United States Animal Plasma and Derivatives Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Animal Plasma and Derivatives Players/Suppliers Profiles and Sales Data
    6.1 Proliant Inc.
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Animal Plasma and Derivatives Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Proliant Inc. Animal Plasma and Derivatives Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Thermo Fisher Scientific, Inc.
        6.2.2 Animal Plasma and Derivatives Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Thermo Fisher Scientific, Inc. Animal Plasma and Derivatives Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Merck KGaA
        6.3.2 Animal Plasma and Derivatives Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Merck KGaA Animal Plasma and Derivatives Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Kraeber & Co GmbH
        6.4.2 Animal Plasma and Derivatives Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Kraeber & Co GmbH Animal Plasma and Derivatives Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 LAMPIRE Biological Laboratories, Inc.
        6.5.2 Animal Plasma and Derivatives Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 LAMPIRE Biological Laboratories, Inc. Animal Plasma and Derivatives Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Lake Immunogenics, Inc.
        6.6.2 Animal Plasma and Derivatives Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Lake Immunogenics, Inc. Animal Plasma and Derivatives Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Rocky Mountain Biologicals Inc.
        6.7.2 Animal Plasma and Derivatives Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Rocky Mountain Biologicals Inc. Animal Plasma and Derivatives Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 ANZCO Foods Ltd.
        6.8.2 Animal Plasma and Derivatives Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 ANZCO Foods Ltd. Animal Plasma and Derivatives Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Auckland BioSciences Ltd.
        6.9.2 Animal Plasma and Derivatives Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Auckland BioSciences Ltd. Animal Plasma and Derivatives Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Bovogen Biologicals Pty Ltd.
        6.10.2 Animal Plasma and Derivatives Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Bovogen Biologicals Pty Ltd. Animal Plasma and Derivatives Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview

7 Animal Plasma and Derivatives Manufacturing Cost Analysis
    7.1 Animal Plasma and Derivatives Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Animal Plasma and Derivatives

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Animal Plasma and Derivatives Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Animal Plasma and Derivatives Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Animal Plasma and Derivatives Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Animal Plasma and Derivatives Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Animal Plasma and Derivatives Sales Volume Forecast by Type (2017-2022)
    11.3 United States Animal Plasma and Derivatives Sales Volume Forecast by Application (2017-2022)
    11.4 United States Animal Plasma and Derivatives Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer